¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Polyarteritis nodosa and related conditions"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® Dilatation and Curettage(D & C) ÇÑ±Û Àڱñܾ¼ú, ÀڱøñÈ®Àå
¼³¸í   
  ÀÚ±ÃÀ̶õ Å¾ư¡ ¼öŵǾ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇϴ °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ Å¾Ƹ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼­ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇϴ ÀڱøñÀ» È®Àå½ÃÄѾߠÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇϴ ¹ý°ú ¼­¼­È÷ È®ÀåÀ» ½ÃµµÇϴ 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ À־ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼­ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼­¼­È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇϴ ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃʷΠ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î ÃµÃµÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³­´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼­ ÀڱüÓÀÇ º´º¯À̳ª ÀӽŵȠžƸ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀǠäÃë ¹× Á¦°Å¸¦ À§Çؼ­µµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. À̴ ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿­ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyarteritis nodosa
    °áÀý¿©·¯µ¿¸Æ¿°, °áÀý´Ù¹ßµ¿¸Æ¿°
  • polyarteritis
    ¿©·¯µ¿¸Æ¿°, ´Ù¹ßµ¿¸Æ¿°
  • arteritis nodosa
    °áÀýµ¿¸Æ¿°
  • arteritis tuberculosa nodosa
    °áÀý°áÇÙµ¿¸Æ¿°
  • conjunctivitis nodosa
    °áÀý°á¸·¿°
  • iridocyclitis nodosa
    °áÀýȫä¼¶¸ðü¿°
  • periarteritis nodosa
    °áÀýµ¿¸ÆÁÖÀ§¿°
  • age-related cognitive decline
    ³ªÀ̰ü·ÃÀÎÁöÀúÇÏ
  • age-related degeneration
    ³ªÀ̰ü·Ãº¯¼º, ³ë³â±âº¯¼º
  • breathing related sleep disorder
    È£Èí°ü·Ã¼ö¸éÀå¾Ö
  • calcitonin gene-related peptide
    Ä®½ÃÅä´ÑÀ¯ÀüÀÚ°ü·ÃÆéƼµå
  • diagnosis related group
    Æ÷°ý¼ö°¡Á¦
  • related
    ±ÙÄ£-
  • stress-related disorder
    ½ºÆ®·¹½º°ü·ÃÀå¾Ö
  • sleep-related epilepsy
    ¼ö¸é°ü·Ã°£Áú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diphteria and tetanus toxoids and acellular pert vaccine
    °³·®µðÇÇÆ¼
  • diagnosis related group
    Æ÷°ý¼ö°¡Á¦
  • polyarteritis
    ´Ù¹ßµ¿¸Æ¿°, ¿©·¯µ¿¸Æ¿°
  • kidney ureter and bladder
    ÄáÆÏ¿ä°ü¹æ±¤´Ü¼øÃÔ¿µ
  • dilatation and curettage
    Àڱñܾ¼ú, ÀÚ±Ã¼ÒÆÄ¼ú
  • peritoneal oocyte and sperm transfer
    »ý½Ä¼¼Æ÷º¹°­³»À̽Ä, »ý½Ä¼¼Æ÷º¹°­³»Àü´Þ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyarteritis nodosa
    °áÀý´Ù¹ßµ¿¸Æ¿°, °áÀý¿©·¯µ¿¸Æ¿°
  • polyarteritis
    ´Ù¹ßµ¿¸Æ¿°, ¿©·¯µ¿¸Æ¿°
  • arteritis nodosa
    °áÀýµ¿¸Æ¿°
  • arteritis tuberculosa nodosa
    °áÀý°áÇÙµ¿¸Æ¿°
  • conjunctivitis nodosa
    °áÀý°á¸·¿°
  • iridocyclitis Nodosa
    °áÀýȫä¼¶¸ðü¿°
  • periarteritis nodosa
    °áÀýµ¿¸ÆÁÖÀ§¿°
  • tinea nodosa
    °áÀý¹é¼±Áõ, °áÀýÇǺΰõÆÎÀÌÁõ
  • trichorrhexis nodosa
    °áÀýÅÐÂõ±èÁõ, °áÀý¿­¸ðÁõ
  • age-related degeneration
    ³ªÀ̰ü·Ãº¯¼º, ³ë³â±âº¯¼º
  • age-related cognitive decline
    ³ªÀ̰ü·ÃÀÎÁöÀúÇÏ
  • sleep-related sinus arrest
    ¼ö¸é°ü·Ã½ÉÀå¹Úµ¿Á¤Áö
  • breathing related sleep disorder
    È£Èí°ü·Ã¼ö¸éÀå¾Ö
  • diagnosis related group
    À¯»çÁø´Ü±ºÀÇ·áºñÁöºÒ¹ý
  • stress-related disorder
    ½ºÆ®·¹½º°ü·ÃÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyarteritis, microscopic
    ´Ù¹ß¼º µ¿¸Æ¿°(ÒýÛ¡àõ ÔÑØææú), ±¤ÇÐÇö¹Ì°æÀû(ÎÃùÊúéÚ°ÌðîÜ)
  • hoof and mouth disease =foot and mouth d.
    ±¸Á¦(¿ª)(Ï¢ð´æ¹) º´.
  • arteritis nodosa
    °áÀý¼º(Ì¿ï½àõ) µ¿¸Æ¿°.
  • arteritis tuberculosa nodosa
    °áÀý¼º °áÇÙ¼º µ¿¸Æ¿°.
  • arthritis nodosa<³ª>
    °áÀý¼º °üÀý¿°(Ì¿ï½àõÎ¼ï½æú).
  • ARC => AIDS-related complex
    ÈÄõ¼º¸é¿ª°áÇÌÁõ°ü·ÃÁõÈıº
  • ARMD->age-related macular degeneration
    ¿¬·É°ü·ÃȲ¹Ýº¯¼º,³ë³â±âȲ¹Ýº¯¼º
  • AlDS-related complex
    ÈÄõ¼º¸é¿ª°áÇÌÁõ°ü·ÃÁõÈıº
  • D-related antigen
    D-°ü·ÃÇ׿ø
  • REM-sleep-related sinus arrest
    ·½¼ö¸é °ü·Ã ½ÉÀ嵿°áÀý(Ô×Ì¿ï½) Á¤Áö
  • age-related cognitive decline
    ¿¬·É °ü·Ã ÀÎÁö ÀúÇÏ
  • fructose-related disorder
    ÇÁ¶ôÅ佺°ü·ÃÀå¾Ö<--Áúº´>
  • hallucinogen-related disorder
    ȯ°¢Á¦ °ü·ÃÀå¾Ö(º´)(ü³ÊÆð¥Î¼Ö¤î¡äô)
  • polysubstance-related disorder
    º¹ÇÕ¹°Áú°ü·ÃÀå¾Ö(º´)
  • related
    ±ÙÄ£(ÐÎöÑ)ÀÇ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyarteritis nodosa
    °áÀý¼º ´Ù¹ß(¼º) µ¿¸Æ¿°(Ì¿ï½àõÒýÛ¡àõÔÑØææú).
  • polyarteritis nodosa
    °áÀý¼º ´Ù¹ß¼ºµ¿¸Æ¿°(Ì¿ï½àõ ÒýÛ¡àõÔÑØææú)
  • polyarteritis nodosa
    °áÀý(¼º) ´Ù¹ßµ¿¸Æ¿°
  • polyarteritis nodosa ³ª
    °áÀý¼º ´Ù¹ß(¼º) µ¿¸Æ¿°(Ì¿ï½àõ ÒýÛ¡(àõ) ÔÑØææú)
  • atmospheric conditions
    ´ë±â»óÅÂ.
  • polyarteritis
    ´Ù¹ß(¼º) µ¿¸Æ¿°(ÒýÛ¡(àõ) ÔÑØææú)
  • polyarteritis, microscopic
    ´Ù¹ß¼º µ¿¸Æ¿°(ÒýÛ¡àõ ÔÑØææú), ±¤ÇÐÇö¹Ì°æÀû(ÎÃùÊúéÚ°ÌðîÜ)
  • hoof and mouth disease =foot and mouth d.
    ±¸Á¦(¿ª)(Ï¢ð´æ¹) º´.
  • papilomatosis of Gougerot and Carteaud => confluent and reticulated pa
  • arteritis nodosa
    °áÀý¼º(Ì¿ï½àõ) µ¿¸Æ¿°.
  • arteritis tuberculosa nodosa
    °áÀý¼º °áÇÙ¼º µ¿¸Æ¿°.
  • arthritis nodosa<³ª>
    °áÀý¼º °üÀý¿°(Ì¿ï½àõÎ¼ï½æú).
  • conjunctivitis nodosa<³ª>
    °áÀý°á¸·¿°(Ì¿ï½Ì¿Ø¯æú).
  • iridocyclitis nodosa ³ª
    °áÀý(Ì¿ï½)ȫä¸ð¾çü¿°.
  • neuritis nodosa ³ª
    °áÀý¼º ½Å°æ¿°.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Tendon sheath of abductor longus and extenor brevis
    ±ä¾öÁö¹ú¸²±Ù°úªÀº¾öÁöÆï±ÙÈûÁÙÁý
    [¿¾ ¿ë¾î] À幫Áö¿ÜÀü±Ù ¹× ´Ü¹«Áö½Å±Ù°ÇÃÊ
  • Lymph nodes of head and neck
    ¸Ó¸® ¹× ¸ñ¸²ÇÁÀý
    [¿¾ ¿ë¾î] µÎ°æºÎÀÓÆÄÀý
  • White matter (Tracts and Fascicles)
    ¹é»öÁú(½Å°æ·Î¿Í ½Å°æ´Ù¹ß)
    [¿¾ ¿ë¾î] ¹éÁú
  • Fold and fossa
    º¹¸·ÁÖ¸§°ú º¹¸·¿À¸ñ
    [¿¾ ¿ë¾î] º¹¸·ÁÖ¸§°ú º¹¸·¿Í
  • Tendon sheath of extensor digitorum and extensor indicis
    ¼Õ°¡¶ôÆï±Ù°úÁý°ÔÆï±ÙÈûÁÙÁý
    [¿¾ ¿ë¾î] Áö½Å±Ù ¹× ½ÃÁö½Å±Ù°ÇÃÊ
  • Sections of thalamus and metathalamus
    ½Ã»ó ¹× ½Ã»óÈĺÎÀÇ ´Ü¸é
    [¿¾ ¿ë¾î] ½Ã»ó ¹× ½Ã»óÈĺÎÀÇ ´Ü¸é
  • Tracts and fascicles of thalamus
    ½Ã»óÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
    [¿¾ ¿ë¾î] ½Ã»ó·Î ¹× ½Ã»ó¼Ó
  • Tracts and fascicles of hypothalamus
    ½Ã»óÇϺÎÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
    [¿¾ ¿ë¾î] ½Ã»óÇϺηΠ¹× ½Ã»óÇϺμÓ
  • Period of mature neural groove and immature somite
    ½Å°æ°í¶û¼º¼÷ ¹× ¸öºÐÀý¹Ì¼º¼÷±â
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÈÄ±â ¹× Ã¼ÀýÇü¼ºÀü±â
  • Medial and inferior surface
    ¾ÈÂÊ¸é ¹× ¾Æ·¡¸é
    [¿¾ ¿ë¾î] ³»Ãø¸é°ú Çϸé
  • Sacral nerves and coccygeal nerve
    ¾ûÄ¡½Å°æ ¹× ²¿¸®½Å°æ
    [¿¾ ¿ë¾î] õ°ñ½Å°æ ¹× ¹Ì°ñ½Å°æ
  • Lobar and segmental bronchi
    ¿±±â°üÁö¿Í ±¸¿ª±â°üÁö
    [¿¾ ¿ë¾î] ¿±±â°üÁö¿Í ±¸±â°üÁö
  • Muscles of palate and fauces
    ÀÔõÀå ¹× ¸ñ±¸¸Û±ÙÀ°
    [¿¾ ¿ë¾î] ±¸°³ ¹× ±¸Çù±Ù
  • Muscles of palate and fauces
    ÀÔõÀå ¹× ¸ñ±¸¸Û±ÙÀ°
    [¿¾ ¿ë¾î] ±¸°³±Ù ¹× ±¸Çù±Ù
  • Mode and course of progress
    ÁøÇà¾ç½Ä ¹× °úÁ¤
    [¿¾ ¿ë¾î] ÁøÇà¾ç½Ä¹×°úÁ¤
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonpermissive conditions
    ºñÇã¿ë Á¶°Ç(ÞªúÉé»ðÉËì)
  • standard conditions
    Ç¥ÁØÁ¶°Ç(øöñÞðÉËì)
  • standard reaction conditions
    Ç¥ÁØ ¹ÝÀÀÁ¶°Ç(øöñÞÚãëëðÉËì)
  • ball and stick model
    °ø ¸·´ë ¸ðµ¨
  • breakage and reunion model
    Àý´ÜÀç°áÇÕ(ï·Ó¨î¢Ì¿ùê)¸ðµ¨
  • cut and patch repair
    Àß¶ó±é±â ¼öº¹(áóÜÖ) (ÔÒ) excision repair
  • Dean and Webb method
    µò°ú¿þºê ¹ý(Ûö)
  • Jacob and Monod hypothesis
    Àð°ö¡¤¸ð³ë ¼³(àã)
  • knife and fork model
    ³ªÀÌÇÁÆ÷Å© ¸ðµ¨
  • "Koshland, Nemethy, and Filmer model"
    "ÄÚ½¬·»µå,³×¸ÞƼ,ÇÊ¸Ó ¸ðµ¨"
  • Lavoisier and Laplace law
    ¶óº¸¾ÆÁ¦ ¶óÇÁ¶óÀ̽º¹ýÄ¢(ÛööÎ)
  • lock and key theory
    ÀÚ¹°¼è-¿­¼èÀÌ·Ð(ìµÖå)
  • modification and restriction
    ¼ö½Ä(áóãÞ)°ú Á¦ÇÑ(ð¤ùÚ)
  • "Monod, Wyman, and Changeux model"
    ¸ð³ë.¿ÍÀ̸¸.¼§Á¶¸ðµ¨
  • Park and Johnson method
    ÆÄÅ© Á¸½¼ ¹ý(Ûö)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyarteritis nodosa
    °áÁ¤¼º´Ù¹ß(¼º)µ¿¸Æ¿°
  • flow related enhancement
    À¯µ¿°ü·ÃÁõ°­
  • polyarteritis
    ´Ù¹ß(¼º) µ¿¸Æ¿°
  • arteritis nodosa
    °áÀý¼ºµ¿¸Æ¿°
  • arthritis nodosa
    °áÀý¼º°üÀý¿°
  • periarteritis nodosa
    °áÀý¼º µ¿¸ÆÁÖÀ§¿°
  • ball and socket joint
    Àý±¸°øÀ̰üÀý
  • ENT [=ear, nose and throat]
    À̺ñÀÎÈİúÇÐ
  • growth and development
    ¼ºÀå°ú ¹ßÀ°
  • infant and child
    ¿µÀ¯¾Æ, À¯¼Ò¾Æ
  • intake and output
    ¼·Ãë¿Í ¹è¼³
  • kidney ureter and bladder [=KUB]
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • KUB [=kidney, ureter and bladder]
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • PACS [=picture archiving and communicating system]
    ÆÑ½º, ¿µ»óÀúÀå ¹× Àü¼Ûü°è
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PN papillary necrosis; parenteral nutrition; penicillin; perceived noise; percussion note; periarteriti...
PAN periarteritis nodosa; periodic alternating nystagmus; peroxyacylnitrate; polyarteritis nodosa; posit...
CEA Carcino-Embryonic Antigen [HP 1825-6]
  ; Oncofetal Antigens
  ; Glycopro...
PAN   1) Poly-Arteritis Nodosa; °áÀý¼º ´Ù¹ß¼º µ¿¸Æ¿°
  2) Peroxy-Acyl-Nitrate
 &nb...
IPN infantile polyarteritis nodosa; infectious pancreatic necrosis [of trout]; intern progress note; int...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PN Polyarteritis Nodosa
ACSC Ambulatory Care Sensitive Conditions
MPA microscopic polyarteritis
PAN periarteriitis nodosa
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • M30
    Polyarteritis nodosa and related conditions
    °áÀý¼º ´Ù¹ßµ¿¸Æ¿° ¹× °ü·Ã »óÅÂ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • polyarteritis
    ´Ù¹ß µ¿¸Æ¿°, ´Ù¹ß¼º µ¿¸Æ¿°
    µ¿¸Æ°èÀÇ ¿©·¯ ºÎÀ§¸¦ ħ¹üÇÏ´Â ¿°Áõ¼º ¹× ±«»ç¼º º´º¯À» Ư¡À¸·Î ÇÏ´Â Áúȯ.
  • reinforcement with operant conditions
    µµ±¸Àû Á¶°ÇÀ» »ç¿ëÇÑ °­È­¹ý
  • arthritis nodosa
    °áÀý¼º °üÀý¿°
  • keratitis nodosa
    °áÀý»ó °¢¸·¿°
  • periarteritis nodosa
    °áÀý¼º µ¿¸Æ ÁÖÀ§¿°
    ½ÅüÀÇ ¼Òµ¿¸Æ°ú ÁßÁõµµ µ¿¸Æº®À» °áÀý»óÀ¸·Î ħ¹üÇÏ´Â ¿°Áõ¼º ÁúȯÀ¸·Î¼­, °¢Á¾ Àü½Å Áõ»óÀ» µ¿¹ÝÇÑ´Ù.
  • salpingitis isthmica nodosa
    °áÀý¼º ÇùºÎ ³­°ü¿°
  • age-related cognitive decline
    ¿¬·É °ü·Ã ÀÎÁö ÀúÇÏ
  • AIDS related complex
    AIDS °ü·Ã º¹ÇÕÁõ, ÈÄõ¼º ¸é¿ª °áÇÌÁõ°ú ¿¬°üµÈ Áúȯ, ÈÄõ¼º ¸é¿ª °áÇÌÁõ-°ü·Ã º¹ÇÕü, ÈÄõ¼º ¸é¿ª °áÇÌÁõ °ü·Ã º¹ÇÕ ¹ÝÀÀ
  • dynorphin-related peptide
    ´ÙÀ̳îÇÉ °ü·Ã ÆéƼµå
  • pain-related disability
    µ¿Åë°ú °ü·ÃµÈ Àå¾Ö
  • parathyroid hormone-related peptide
    ºÎ°©»ó¼± È£¸£¸ó ¿¬°ü ÆéŸÀ̵å
  • polysubstance-related disorder
    º¹ÇÕ ¹°Áú °ü·Ã Àå¾Öº´
  • related
    ±ÙÄ£ÀÇ
  • related heteroantigen
    ÀÌÁ¾ Ç׿ø
  • related sulfonamide diuretics

    relation (À§Ä¡, °ü°è

    ¾î´À ¹°Ã¼ ¶Ç´Â ½Çü°¡ µý °Í°ú °ü·ÃÀ» °¡Áö°í ÀÖ´Ù°í »ý°¢µÇ´Â »óÅÂ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
polyarteritis nodosa <radiology> Necrotizing vasculitis of medium-sized arteries, usually in male adults, associated with hepatitis B antigen, kidney: most frquently involved organ (85%), multiple small intrarenal aneurysms, aneurysms may disappear (thrombosis) or appear in new locations, arterial narrowing and thrombosis (chronic/healing stage), multiple small cortical infarcts, associated with hypertension and renal failure, chest involvement (70%), cardiomegaly/pericardial effusion (14%), wedge shaped/round peripheral infiltrates simulating PE (14%), interstitial lower lung field pneumonitis, also may involve liver (66%), mesenteric vessels (50%), skeletal muscle (39%), skin (20%)
(12 Dec 1998)
polyarteritis Simultaneous inflammation of a number of arteries.
(05 Mar 2000)
precancerous conditions Pathological processes that tend eventually to become malignant.
(12 Dec 1998)
saline conditions Soils or waters that are high in salt content, that is, more than 0.5 parts per thousand (=0.05% salinity). Usually sodium chloride (NaCl) is the predominant salt, but some areas have high concentrations of sulphates, carbonates, and bicarbonates, as well. Habitats are commonly subdivided on the basis of total salt content.
(09 Oct 1997)
social conditions The state of society as it exists or in flux. While it usually refers to society as a whole in a specified geographical or political region, it is applicable also to restricted strata of a society.
(12 Dec 1998)
thermonuclear conditions <radiobiology> Achievement of an adequately confined plasma, having temperature and density sufficiently high to yield significant release of energy from fusion reactions.
(09 Oct 1997)
arteritis nodosa <radiology> Necrotizing vasculitis of medium-sized arteries, usually in male adults, associated with hepatitis B antigen, kidney: most frquently involved organ (85%), multiple small intrarenal aneurysms, aneurysms may disappear (thrombosis) or appear in new locations, arterial narrowing and thrombosis (chronic/healing stage), multiple small cortical infarcts, associated with hypertension and renal failure, chest involvement (70%), cardiomegaly/pericardial effusion (14%), wedge shaped/round peripheral infiltrates simulating PE (14%), interstitial lower lung field pneumonitis, also may involve liver (66%), mesenteric vessels (50%), skeletal muscle (39%), skin (20%)
(12 Dec 1998)
arthritis nodosa <disease> A systemic disease, seen more commonly in women which affects connective tissue, particularly the synovial tissue within joints. Arthritis is the main clinical feature and involves many joints in the body, especially those of the hand and feet. In this disease, there is thickening of the soft tissues around the joints and extension of the synovial tissue over articular cartilage (which becomes eroded).
A chronic and progressive course is common with joint deformities and disability. Juvenile rheumatoid arthritis is a variant which affects children.
(11 Nov 1997)
vasitis nodosa An inflammatory condition of the vas deferens characterised by the presence of numerous epithelium-lined spaces with the muscularis and adventitia, often containing spermatozoa; usually seen after vasectomy, and may clinically and microscopically mimic adenocarcinoma.
See: vas deferens
(05 Mar 2000)
periarteritis nodosa <radiology> Necrotizing vasculitis of medium-sized arteries, usually in male adults, associated with hepatitis B antigen, kidney: most frquently involved organ (85%), multiple small intrarenal aneurysms, aneurysms may disappear (thrombosis) or appear in new locations, arterial narrowing and thrombosis (chronic/healing stage), multiple small cortical infarcts, associated with hypertension and renal failure, chest involvement (70%), cardiomegaly/pericardial effusion (14%), wedge shaped/round peripheral infiltrates simulating PE (14%), interstitial lower lung field pneumonitis, also may involve liver (66%), mesenteric vessels (50%), skeletal muscle (39%), skin (20%)
(12 Dec 1998)
salpingitis isthmica nodosa An abnormal condition of the fallopian tube in the place where it attaches to the uterus, characterised by nodules.
(09 Oct 1997)
dermatitis nodosa A papular eruption on the legs, related to craw-craw.
(05 Mar 2000)
ophthalmia nodosa The presence of nodular swellings on the conjunctiva, due to penetration of ocular tissues by the hairs of caterpillars.
Synonym: caterpillar-hair ophthalmia.
(05 Mar 2000)
endophthalmitis ophthalmia nodosa Endophthalmitis due to intraocular caterpillar hairs.
See: ophthalmia nodosa.
(05 Mar 2000)
trichomycosis nodosa Corynebacterium infection of axillary and pubic hairs with development of yellow (flava), black (nigra), or red (rubra) concretions around the hair shafts; frequently asymptomatic.
Synonym: lepothrix, Paxton's disease, trichomycosis chromatica, trichomycosis nodosa, trichomycosis nodularis, trichomycosis palmellina, trichonocardiosis axillaris, trichonodosis.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • related
    °ü°è°¡ ÀÖ´Â
  • Earnings Related Supplement
    (¿µ)º¸Çè ±ÞºÎ±Ý(¿µ±¹ÀÇ »çȸº¸ÀåÁ¦µµ¿¡¼­ 6°³¿ù°£ ½Ç¾÷ÀÚ(ȯÀÚ)¿¡°Ô Àü³âµµ ¼Òµæ¿¡ µû¶ó Áö±ÞµÊ)
  • related
    °ü°è°¡ ÀÖ´Â;°ü·ÃµÈ;Ä£Á·ÀÇ;µ¿Á·ÀÇ
  • related key
    (ÁÖÀ½ µî°ú °¡±î¿î °ü°è°¡ ÀÖ´Â)±ÙÄ£(°ü°è)Á¶
  • again and again
    ¹Ýº¹Çؼ­
  • and
    ±×¸®°í
  • and not ~ either
    ¶Ç ~ ¾Æ´Ï´Ù(=nor)
  • and so forth
    ±âŸ µîµî
  • and so on
    ..µîµî
  • and such
    µûÀ§,µîµî
  • and that
    ±×°Íµµ,°Ô´Ù°¡
  • both ~ and -
    ~ µµ - µµ (µÑ´Ù)
  • by and by
    ÀÌÀ¹°í
  • by-and-by
    ¹Ì·¡
  • checks and balances
    °ßÁ¦¿Í ±ÕÇü
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á